Literature DB >> 15243114

Use of two sensitive and specific immunoblot markers, em70 and em90, for diagnosis of alveolar echinococcosis.

Metin Korkmaz1, Tonay Inceboz, Fehmi Celebi, Aylin Babaoglu, Ahmet Uner.   

Abstract

Antibodies against Echinococcus multilocularis metacestodes were screened by immunoblotting sera from patients with alveolar echinococcosis (n = 39), cystic echinococcosis (n = 109), or other parasitic infections (n = 66) and healthy individuals (n = 32). Two antigens, approximately 70 and 90 kDa, are found to be valuable for confirmatory diagnosis, with a sensitivity and specificity of 100 and 99.51%, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243114      PMCID: PMC446319          DOI: 10.1128/JCM.42.7.3350-3352.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Immunodiagnosis of alveolar echinococcosis by enzyme-linked immunosorbent assay using a partially purified Em18/16 enriched fraction.

Authors:  A Ito; L Ma; M Itoh; S Y Cho; Y Kong; S Y Kang; T Horii; X L Pang; M Okamoto; T Yamashita; M W Lightowlers; X G Wang; Y H Liu
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

2.  Alveolar echinococcosis: Em2plus-ELISA and Em18-western blots for follow-up after treatment with albendazole.

Authors:  L Ma; A Ito; Y H Liu; X G Wang; Y Q Yao; D G Yu; Y T Chen
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Jul-Aug       Impact factor: 2.184

3.  Immunoblot evaluation of the species-specificity of Em18 and Em16 antigens for serodiagnosis of human alveolar echinococcosis.

Authors:  N Nirmalan; P S Craig
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Jul-Aug       Impact factor: 2.184

4.  Immunodiagnosis of Echinococcus infections: confirmatory testing and species differentiation by a new commercial Western Blot.

Authors:  M Liance; V Janin; S Bresson-Hadni; D A Vuitton; R Houin; R Piarroux
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

5.  Antibodies against Echinococcus multilocularis alkaline phosphatase as markers for the specific diagnosis and the serological monitoring of alveolar echinococcosis.

Authors:  E M Sarciron; S Bresson-Hadni; M Mercier; P Lawton; C Duranton; D Lenys; A F Petavy; D A Vuitton
Journal:  Parasite Immunol       Date:  1997-02       Impact factor: 2.280

6.  Serological differentiation between cystic and alveolar echinococcosis by use of recombinant larval antigens.

Authors:  M Helbig; P Frosch; P Kern; M Frosch
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

7.  A large focus of alveolar echinococcosis in central China.

Authors:  P S Craig; L Deshan; C N MacPherson; S Dazhong; D Reynolds; G Barnish; B Gottstein; W Zhirong
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

8.  Differential serodiagnosis of alveolar and cystic hydatid disease in the People's Republic of China.

Authors:  A Ito; X G Wang; Y H Liu
Journal:  Am J Trop Med Hyg       Date:  1993-08       Impact factor: 2.345

9.  Improved primary immunodiagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus antigen.

Authors:  B Gottstein; P Jacquier; S Bresson-Hadni; J Eckert
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

10.  Em18, a new serodiagnostic marker for differentiation of active and inactive cases of alveolar hydatid disease.

Authors:  A Ito; P M Schantz; J F Wilson
Journal:  Am J Trop Med Hyg       Date:  1995-01       Impact factor: 2.345

View more
  3 in total

Review 1.  The global burden of alveolar echinococcosis.

Authors:  Paul R Torgerson; Krista Keller; Mellissa Magnotta; Natalie Ragland
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

Review 2.  Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay.

Authors:  Dominique Angèle Vuitton; Bruno Gottstein
Journal:  J Biomed Biotechnol       Date:  2010-03-21

3.  A rare case of cardiac alveolar echinococcosis without any complications for eight years.

Authors:  D Çelik; I Ödemiş; M Korkmaz; S Köse
Journal:  Rev Esp Quimioter       Date:  2021-11-26       Impact factor: 1.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.